Internet-based Treatment of Generalized Anxiety Disorder

October 31, 2016 updated by: Per Carlbring, PhD, Umeå University
The purpose of this study is to determine whether internet-administered cognitive behavior therapy is a feasible treatment for generalized anxiety disorder.

Study Overview

Study Type

Interventional

Enrollment (Actual)

103

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Västerbotten
      • Umeå, Västerbotten, Sweden, 90181
        • Department of Psychology, Umeå University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Satisfy DSM-IV criteria for generalized anxiety disorder
  • Living in Sweden and being able to read Swedish
  • Access to computer with internet connection

Exclusion Criteria:

  • Currently receiving other psychological treatment
  • Non-stable use of psychoactive medication
  • Deemed suicidal
  • Deemed to suffer from other psychological disorder, e.g. psychosis, bipolarity etc.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: iCBT
Receives treatment.
9 week internet-administered, therapist-assisted, controlled-progression cognitive behavioral therapy (iCBT). Individualized and disorder-specific.
NO_INTERVENTION: Waiting list control group
The waiting list control group initially receives no treatment, but do weekly screenings. After 9 weeks, the control group receives the same treatment as the other study arm.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline in Penn State Worry Questionnaire (PSWQ)
Time Frame: 24 hours
Measures anxiety symptoms related to Generalized Anxiety Disorder. 16 items.
24 hours
Change from baseline in Penn State Worry Questionnaire (PSWQ)
Time Frame: 6 months
Measures anxiety symptoms related to Generalized Anxiety Disorder. 16 items.
6 months
Change from baseline in Penn State Worry Questionnaire (PSWQ)
Time Frame: 12 months
Measures anxiety symptoms related to Generalized Anxiety Disorder. 16 items.
12 months
Change from baseline in Penn State Worry Questionnaire (PSWQ)
Time Frame: 24 months
Measures anxiety symptoms related to Generalized Anxiety Disorder. 16 items.
24 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline in Beck Anxiety Inventory (BAI)
Time Frame: 24 hours
21 item rating scale for anxiety symptoms.
24 hours
Change from baseline in Beck Anxiety Inventory (BAI)
Time Frame: 6 months
21 item rating scale for anxiety symptoms.
6 months
Change from baseline in Beck Anxiety Inventory (BAI)
Time Frame: 12 months
21 item rating scale for anxiety symptoms.
12 months
Change from baseline in Beck Anxiety Inventory (BAI)
Time Frame: 24 months
21 item rating scale for anxiety symptoms.
24 months
Change from baseline in Quality Of Life Inventory (QOLI)
Time Frame: 24 hours
The QOLI assessment yields an overall score and a profile of problems and strengths in 16 areas of life such as love, work and play. The QOLI test is a measure of positive psychology and positive mental health.
24 hours
Change from baseline in Quality Of Life Inventory (QOLI)
Time Frame: 6 months
The QOLI assessment yields an overall score and a profile of problems and strengths in 16 areas of life such as love, work and play. The QOLI test is a measure of positive psychology and positive mental health.
6 months
Change from baseline in Quality Of Life Inventory (QOLI)
Time Frame: 12 months
The QOLI assessment yields an overall score and a profile of problems and strengths in 16 areas of life such as love, work and play. The QOLI test is a measure of positive psychology and positive mental health.
12 months
Change from baseline in Quality Of Life Inventory (QOLI)
Time Frame: 24 months
The QOLI assessment yields an overall score and a profile of problems and strengths in 16 areas of life such as love, work and play. The QOLI test is a measure of positive psychology and positive mental health.
24 months
Change from baseline in Montgomery-Åsberg Depression Rating Scale (MADRS)
Time Frame: 24 hours
9-item depression rating scale.
24 hours
Change from baseline in Montgomery-Åsberg Depression Rating Scale (MADRS)
Time Frame: 6 months
9-item depression rating scale.
6 months
Change from baseline in Montgomery-Åsberg Depression Rating Scale (MADRS)
Time Frame: 12 months
9-item depression rating scale.
12 months
Change from baseline in Montgomery-Åsberg Depression Rating Scale (MADRS)
Time Frame: 24 months
9-item depression rating scale.
24 months
Change from baseline in Patient Health Questionnaire (PHQ-9)
Time Frame: Weekly during treatment period
The PHQ-9 is the nine item depression scale of the Patient Health Questionnaire. The PHQ-9 is a powerful tool for assisting primary care clinicians in diagnosing depression as well as selecting and monitoring treatment. The PHQ-9 is based directly on the diagnostic criteria for major depressive disorder in the Diagnostic and Statistical Manual Fourth Edition (DSM-IV).
Weekly during treatment period
Change from baseline in Patient Health Questionnaire (PHQ-9)
Time Frame: 24 hours
The PHQ-9 is the nine item depression scale of the Patient Health Questionnaire. The PHQ-9 is a powerful tool for assisting primary care clinicians in diagnosing depression as well as selecting and monitoring treatment. The PHQ-9 is based directly on the diagnostic criteria for major depressive disorder in the Diagnostic and Statistical Manual Fourth Edition (DSM-IV).
24 hours
Change from baseline in Patient Health Questionnaire (PHQ-9)
Time Frame: 6 months
The PHQ-9 is the nine item depression scale of the Patient Health Questionnaire. The PHQ-9 is a powerful tool for assisting primary care clinicians in diagnosing depression as well as selecting and monitoring treatment. The PHQ-9 is based directly on the diagnostic criteria for major depressive disorder in the Diagnostic and Statistical Manual Fourth Edition (DSM-IV).
6 months
Change from baseline in Patient Health Questionnaire (PHQ-9)
Time Frame: 12 months
The PHQ-9 is the nine item depression scale of the Patient Health Questionnaire. The PHQ-9 is a powerful tool for assisting primary care clinicians in diagnosing depression as well as selecting and monitoring treatment. The PHQ-9 is based directly on the diagnostic criteria for major depressive disorder in the Diagnostic and Statistical Manual Fourth Edition (DSM-IV).
12 months
Change from baseline in Patient Health Questionnaire (PHQ-9)
Time Frame: 24 months
The PHQ-9 is the nine item depression scale of the Patient Health Questionnaire. The PHQ-9 is a powerful tool for assisting primary care clinicians in diagnosing depression as well as selecting and monitoring treatment. The PHQ-9 is based directly on the diagnostic criteria for major depressive disorder in the Diagnostic and Statistical Manual Fourth Edition (DSM-IV).
24 months
Change from baseline in Generalized Anxiety Disorder-7 (GAD-7)
Time Frame: Weekly during treatment period
7-item screening form for Generalized Anxiety Disorder.
Weekly during treatment period
Change from baseline in Generalized Anxiety Disorder-7 (GAD-7)
Time Frame: 24 hours
7-item screening form for Generalized Anxiety Disorder.
24 hours
Change from baseline in Generalized Anxiety Disorder-7 (GAD-7)
Time Frame: 6 months
7-item screening form for Generalized Anxiety Disorder.
6 months
Change from baseline in Generalized Anxiety Disorder-7 (GAD-7)
Time Frame: 12 months
7-item screening form for Generalized Anxiety Disorder.
12 months
Change from baseline in Generalized Anxiety Disorder-7 (GAD-7)
Time Frame: 24 months
7-item screening form for Generalized Anxiety Disorder.
24 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2012

Primary Completion (ACTUAL)

January 1, 2016

Study Completion (ACTUAL)

February 1, 2016

Study Registration Dates

First Submitted

March 31, 2012

First Submitted That Met QC Criteria

April 3, 2012

First Posted (ESTIMATE)

April 4, 2012

Study Record Updates

Last Update Posted (ESTIMATE)

November 1, 2016

Last Update Submitted That Met QC Criteria

October 31, 2016

Last Verified

October 1, 2016

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Generalized Anxiety Disorder

Clinical Trials on Internet-based cognitive behavioral therapy (iCBT)

3
Subscribe